Navigation Links
Vicus Therapeutics Announces Initiation of Phase 2 Trial to Evaluate VT-122 in Patients with Liver Cancer Receiving Nexavar
Date:12/27/2010

rtant processes that enable cancer growth.  These kinases included Raf kinase, VEGFR-1, VEGFR-2, VEGFR-3, PDGFR-B, KIT, FLT-3 and RET.  

Nexavar is currently approved in 99 countries.  

Nexavar is also being evaluated by the companies, international study groups, government agencies and individual investigators.

Important Safety Considerations For Patients Taking Nexavar

NEXAVAR in combination with carboplatin and paclitaxel is contraindicated in patients with squamous cell lung cancer. Nexavar may cause fetal harm when administered to a pregnant woman. Women of childbearing potential are advised to avoid becoming pregnant and Female patients should also be advised against breast-feeding while receiving Nexavar.

Cardiac ischemia and/or myocardial infarction may occur. Temporary or permanent discontinuation of Nexavar should be considered in patients who develop cardiac ischemia and/or myocardial infarction.  Gastrointestinal perforation was an uncommon adverse reaction and has been reported in less than 1% of patients taking Nexavar.

Uncommon but serious adverse reactions including keratoacanthomas/squamous cell cancer of the skin and Stevens - Johnson Syndrome have been reported in clinical trials

An increased risk of bleeding may occur following Nexavar administration. If bleeding necessitates medical intervention, consider discontinuation of Nexavar.

Hypertension may occur early in the course of treatment. Monitor blood pressure weekly during the first 6 weeks and periodically thereafter and treat, as required.

Hand-foot skin reaction and rash are common and management may include topical therapies for symptomatic relief.  In cases of any severe or persistent adverse reactions, temporary treatment interruption, dose modification, or permanent discontinuation of Nexavar should be considered.

Temporary interruption of Nexavar therapy is recommended in
'/>"/>

SOURCE Vicus Therapeutics, LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Vicus Therapeutics Records Last Patient Visit of Phase 2, VT-122 Trial for the Treatment of Cachexia in Patients With Advanced Lung Cancer
2. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
3. King Pharmaceuticals and Pain Therapeutics Announce Resubmission of New Drug Application for REMOXY®
4. PTC Therapeutics Completes Enrollment of Phase 3 Trial of Ataluren in Patients with Cystic Fibrosis
5. Silence Therapeutics Provides Year-end Update
6. Angelica Therapeutics Receives a $244,479 Qualified Therapeutic Discovery Project Grant for Its Anti-Cancer Drug
7. Talecris Biotherapeutics Enrolls Patients in Clinical Trial Evaluating Two Doses of PROLASTIN®-C
8. Osseon® Therapeutics Names Gary Coughlen, CPA as New Chief Financial Officer
9. Amicus Therapeutics Awarded $500,000 Grant from The Michael J. Fox Foundation for Development of Next-Generation Pharmacological Chaperone to Treat Parkinsons Disease
10. Orexigen® Therapeutics Investigational Drug Contrave® Receives Positive Recommendation from FDA Advisory Committee for Treatment of Obesity
11. Nile Therapeutics Receives NASDAQ Notice; Will Request Hearing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... -- Strategic Health Services, Inc. (SHS), a leading provider of ... agreement with QualCare, Inc., a leading provider of health plans ... marketplace.  This agreement will further QualCare,s population health management ... brings to its clients in New Jersey ... QualCare plans cover more than 800,000 member lives, with ...
(Date:12/17/2014)... December 17, 2014 , ... than a hub of information concerning the biopharmaceutical Group,s national ... A further addition to the recently launched institutional website that ... now been enriched by a new chapter in the fascinating ... A richly detailed and panoramic hub on the world of ...
(Date:12/17/2014)... RALEIGH, N.C. , Dec. 17, 2014 ... and Integrated Clinical Trial Services, LLC (ICTS), two ... clinical trials announce that they have formed a ... (i-CTMS). i-CTMS will provide a broad range of ... and medical device companies. i-CTMS will ...
Breaking Medicine Technology:Strategic Health Services to collaborate with QualCare on Population Health and Wellness Technology for QualCare Members 2Strategic Health Services to collaborate with QualCare on Population Health and Wellness Technology for QualCare Members 3Dompé Offers a New "Window" on the World of Scientific Research, with the http://www.dompetrials.com Website, Dedicated to Clinical Trials 2Dompé Offers a New "Window" on the World of Scientific Research, with the http://www.dompetrials.com Website, Dedicated to Clinical Trials 3Integrated Clinical Trial Services and Clinical Trial Marketing Communications Form Joint Venture 2Integrated Clinical Trial Services and Clinical Trial Marketing Communications Form Joint Venture 3
... IDM Pharma, Inc.,(Nasdaq: IDMI ) today ... for Medicinal Products for Human Use (CHMP) and ... 25th, following the,CHMP,s September meeting where CHMP considered ... for the,treatment of patients with non-metastatic, resectable osteosarcoma, ...
... Preventing Possibly Life-Threatening,Condition During Air Travel, ALEXANDRIA, ... (APTA) supports the recent "Call to Action" by,Acting ... reduce the number of,cases of deep vein thrombosis ... According to Susan Scherer, PT, PhD, associate professor ...
Cached Medicine Technology:IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following September Meeting of European Committee for Medicinal Products for Human Use (CHMP) 2IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following September Meeting of European Committee for Medicinal Products for Human Use (CHMP) 3IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following September Meeting of European Committee for Medicinal Products for Human Use (CHMP) 4IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following September Meeting of European Committee for Medicinal Products for Human Use (CHMP) 5APTA Supports Surgeon General's 'Call to Action' to Prevent Deep Vein Thrombosis and Pulmonary Embolism 2APTA Supports Surgeon General's 'Call to Action' to Prevent Deep Vein Thrombosis and Pulmonary Embolism 3
(Date:12/15/2014)... CITY, NV (PRWEB) December 15, 2014 ... powerhouse company, JM Ocean Avenue. JM Ocean Avenue ... of the Veretekk online automated marketing system. JM ... the June 2014 merger of Ocean Avenue and JM ... more than $2 Billion per year company. , “After ...
(Date:12/15/2014)... 15, 2014 OutMarket , a ... “ Social Media Cheat Sheets ,” a guide that ... drives results on the top ten social media networks. ... helps drive awareness, engagement, and customer service. It can ... make an impact on new networks and weather constantly ...
(Date:12/15/2014)... 2014 The increase in prevalence of disabling ... main factors which is contributing to the growth in the ... and treatment of hearing loss and balance disorders are known ... - microphone, speaker and amplifier. The global market is expected ... during the period from 2014 to 2019. Some of the ...
(Date:12/15/2014)... 2014 At the leading, long-established event ... and Focus Autism will welcome scientists ... on the effects of toxins to children’s health, as ... , Luminaries such as Dr. Lucija Tomljenovic and ... esteemed, credentialed colleagues of the United States to present ...
(Date:12/15/2014)... Metal drilling machines have a ... score indicates that neither buyers nor suppliers have a ... been raising the price of metal drilling machines during ... demand,” according to IBISWorld business research analyst, Jeffrey Cohen. ... the past three years, high price driver volatility has ...
Breaking Medicine News(10 mins):Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 2Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 3Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 4Health News:OutMarket Releases Cheat Sheets for Social Media Marketing 2Health News:OutMarket Releases Cheat Sheets for Social Media Marketing 3Health News:Audiological Devices Market 2019 Demand for Esthetic Hearing Aids Drives the Growth, Says a Report at ReportsnReports.com 2Health News:Audiological Devices Market 2019 Demand for Esthetic Hearing Aids Drives the Growth, Says a Report at ReportsnReports.com 3Health News:Audiological Devices Market 2019 Demand for Esthetic Hearing Aids Drives the Growth, Says a Report at ReportsnReports.com 4Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 3Health News:Metal Drilling Machines Procurement Category Market Research Report Now Available from IBISWorld 2Health News:Metal Drilling Machines Procurement Category Market Research Report Now Available from IBISWorld 3
... ... Asks What’s Next for Doctors under New Healthcare Reform Bill, , ... Dallas, TX (Vocus) April 19, 2010 – The recent ... ’ ( Brown Books ) addresses how the health care system has been hostage for ...
... ... ... 18, 2010 -- This weekend, more than 30,000 attendees at the International Cannabis & ... to the nation’s first retail branded, complete medical marijuana product line. , , ,YAK ...
... to help with care, researchers say , SUNDAY, April 18 ... ill older people in the United States live alone, a ... to take care of their parents and relatives, a new ... significantly help many patients with chronic illness manage their health ...
... ... North East Alabama, has successfully completed deployment of CellTrak workflow automation and visit compliance ... HR payroll. , ... Schaumburg, IL (PRWEB) April 18, 2010 -- ABC Hospice, Inc, a premier hospice provider ...
... ... Washington, hits the big time , ... Oak Harbor, WA (PRWEB) April 19, 2010 -- In the highly-competitive natural skincare industry, ... Tacia, Oak Harbor resident and owner of Bella Vé Natural Skin Care, has recently launched ...
... faster times as the goal, while females hope to ... -- Women run marathons to feel good while men run ... suggests. , The research included 507 female and 399 male ... questionnaire designed to reveal the participants, motivation for taking part ...
Cached Medicine News:Health News:Recent Book Moves Beyond Defensive Medicine, Tackles Entitlement Reform 2Health News:Recent Book Moves Beyond Defensive Medicine, Tackles Entitlement Reform 3Health News:First Retail Branded Edible Medical Marijuana Product Line Introduced at San Francisco Trade Show 2Health News:First Retail Branded Edible Medical Marijuana Product Line Introduced at San Francisco Trade Show 3Health News:First Retail Branded Edible Medical Marijuana Product Line Introduced at San Francisco Trade Show 4Health News:1 in 4 Chronically Ill Elderly Lives Alone 2Health News:CellTrak Increases Employee Productivity and Efficiencies at ABC Hospice, Inc. 2Health News:CellTrak Increases Employee Productivity and Efficiencies at ABC Hospice, Inc. 3Health News:Hollywood Eco-Celebrity Rachelle Carson-Begley Gives Skincare Company Bella V Rave Reviews 2Health News:Hollywood Eco-Celebrity Rachelle Carson-Begley Gives Skincare Company Bella V Rave Reviews 3Health News:Hollywood Eco-Celebrity Rachelle Carson-Begley Gives Skincare Company Bella V Rave Reviews 4Health News:Are Male Marathoners More Competitive Than Women? 2
... assays are designed for ... 2000, a high-throughput, continuous ... IMMULITE 2000 offers testing ... a rapidly expanding menu ...
... radiography. The XPERT represents a research tool that ... in every digital x-ray image, thus being able ... heretofore were lost to the human eye. With ... to 8 x 8 in size, multi-color digital ...
The Solar Radius Chair is a multi-functional and cost effective working environment. It can be used for simple and advanced urodynamic studies as well as for routine gynecology investigations....
... is the ultimate in positioning ... popular accessories, the 6202 is ... of exam and treatment procedures. ... allow fast & precise positioning ...
Medicine Products: